The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis in Gulf Countries: DERMIND-AD

drug protocol number
OBS18647
drug sponsor
Sanofi
drug study
Dupilumab
drug trial site
Fakeeh Medical Center (Jeddah)
drug status
Ongoing
drug phase